期刊文献+

中西医结合疗法对非小细胞肺癌患者sCD44v6的影响 被引量:5

The Effect on the sCD44v6 of NSCLC Patient by the Therapy of Combination of TCM with Western Medicine
下载PDF
导出
摘要 目的:通过对非小细胞肺癌患者可溶性CD44V6(sCD44v6)的观察,研究中药结合化疗对该指标的作用。方法:随机分为3组:即中药加化疗的中西医结合治疗组、单纯中药对照组和单纯化疗对照组。治疗组采用中药辨证加化疗,对照组采用单纯中药或单纯化疗,化疗方案均采用NP或MVP方案。疗程2个周期。结果:sCD44v6治疗后治疗组明显降低,P<0.05。以上3组治疗后结果组间比较显示,sCD44v6水平治疗组显著低于单纯中药对照组,P<0.05。结论:中西医结合治疗能使中晚期非小细胞肺癌血液中的sCD44v6水平下降。 Objectives : This study explores the effect on sCD44V6 by combining Chinese drugs with chemiotherapy by observing the indexes of sCD44V6. Methods - the patients were divided into three groups at random: the treatment group treated by chemiotherapy combined with Chinese drugs, the two control groups treated respectively by Chinese drugs and chemiotherapy. The chemiotherapy regimens are NP or MVP. The course of treatment is two cycle time. Results : The serum levels of soluble CD44V6 of the treatment group decreased significantly after therapy, P 〈 0.05. Comparison of the serum level of sCD44V6 among the three groups after therapy, the treatment group significantly lower than the Chinese drug group, P 〈 0. 05. Conclusion : The therapy of combination of TCM with western medicine can lower the level of sCD44V6 of middle and advanced stage NSCLC.
作者 李雁
出处 《中华中医药学刊》 CAS 2008年第4期704-706,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 中西医结合疗法 中药疗法 化学疗法 非小细胞肺癌 SCD44V6 therapy of combination of TCM with western medicine the therapy of Chinese drugs chemiotherapy non- small -cell lung cancer sCD44v6
  • 相关文献

参考文献9

  • 1[1]A1belda SM.Role of integrins and othe cell adhesion molecules in tumor progression and metastasis[J].Cell,1993,68:4-17.
  • 2程湘.CD44分子的结构特征[J].国外医学(免疫学分册),1998,21(4):185-188. 被引量:8
  • 3[3]Fasano M,Sabatini MT,Wieczored R,et al.CD44 and its v6 spliced variant in lung tumors[J].Cancer,1997,80:34-41.
  • 4[4]Penno MB,Augrst J,Baylin SB,et al.Expression of CD44 in buman[J].Lung Cancer Res,1994,45:1381-1387.
  • 5[5]Tran TA,Kallakuy BVS,Sheehan CE.et al.Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas[J].Human Pathology,1997,28:809-814.
  • 6金可可,蒋仲荪,陈少贤,徐正衸,龚永生.血清CD44及其拼接变异体sCD44v6测定对肺癌的诊治意义[J].温州医学院学报,2000,30(3):190-192. 被引量:3
  • 7何秋莎,陈彦凡,龚永生.血浆表达CD44分子几种基因拼接体的临床诊断价值[J].温州医学院学报,2000,30(2):109-111. 被引量:6
  • 8[8]Tran TA,Kallakuy BVS,Sheehan CE.et al.Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas[J].Human Pathology,1997,28:809-814.
  • 9[9]Haynes BF,Telen MJ,Hale LP,et al.CD44-a molecule involved in leukocyte adherence and T-cell activation[J].Immunol Today,1989,10(12):423-428.

二级参考文献7

  • 1WielengaVJ,HeiderKH,offerhausGJ,etal.ExpressionofCD44variantproteinsinhumancdorectalcancerisrelatedtotumorprogression.CancerRes,1993,53:4754-4556.
  • 2MatsumuvaY,TarinD.SignificanceofCD44geneproductsforcancerdiagnosisanddiseaseevaluation[seecomm-ents].Lancet,1992,340:1053-1058.
  • 3TarinD,MatsumuraY.DerangedCD44geneactivityinmalignancy[editorial].JPatho,1993,171:249-250.
  • 4HofmannM,RudyW,GunthertU,etal.Alinkbetweenrasandmetastaticbehavioroftumorcells:rasinducesCD44promotoractivityandleadstolow-levelexpressionofmetastasis-specificvariantsofCD44increfcells.CancerRas,1993,53:1516-1521.
  • 5欧启水.CD44与肿瘤关系研究进展[J].国外医学(临床生物化学与检验学分册),1998,19(4):161-163. 被引量:11
  • 6戴备军,赵仲生.CD44V6在非小细胞肺癌中的表达及其预后意义[J].实用肿瘤杂志,1998,13(4):214-216. 被引量:20
  • 7李祖国,丁彦青,邓永键,朱梅刚.CD44V6的表达对大肠癌细胞骨架的影响[J].中华病理学杂志,1998,27(4):273-277. 被引量:13

共引文献14

同被引文献51

引证文献5

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部